Our Mission is to Reduce Late Stage Cancer by 50% Over the Next Ten Years through Early Interventions
GeneNews (TSX:GEN) is dedicated to providing innovative solutions for early cancer detection. Our goal is to provide advanced diagnostics that can help physicians and patients identify cancer at the earliest possible stage, when it is the most curable. Our CAP accredited laboratory, Innovative Diagnostic Laboratory (IDL), is a clinical reference lab based in Richmond, Virginia that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. Our goal is to provide the best cancer risk assessment tests that are available today for early cancer risk assessment.